Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-94.18	5.99	-103.01
Graham Fair Price	-83.86	24691.65	152988.07
PEG	91078.69	-0.04	< 0.005
Price/Book	-5.19	0.16	0.17
Price/Cash Flow	198.75	6.06	2.03
Prices/Earnings	3549.99	4.00	0.11
Price/Sales	-1.36	0.58	0.59
Price/FCF	198.75	6.06	2.03
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	27.15	0.09	0.07
Operating Margin	61.38	0.03	-0.02
ROA	-97.44	< 0.005	0.25
ROE	0.38	< 0.005	-97.40
ROIC	-0.01	< 0.005	-57.61
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	< 0.005	5273.11
Dividends QOQ	0.48	1.35	181.19
EBIT QOQ	-1.47	2.55	74.03
EPS QOQ	24.33	-0.97	-96.00
FCF QOQ	1.90	-0.68	-64.08
Revenue QOQ	0.02	-0.04	107.25
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	47.05	52.41	11.41
Days Sales Outstanding (DSO)	70.82	75.50	6.61
Inventory Turnover	1.91	1.72	-10.24
Debt/Capitalization	0.12	0.11	-6.95
Quick Ratio	1.24	1.20	-3.27
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	52449.76	52524.21	0.14
Cash	10041.87	10464.18	4.21
Capex	9.28	-86.66	834.03
Free Cash Flow	4291.71	1363.89	-68.22
Revenue	14692.79	14141.96	-3.75
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.70	1.65	-3.11
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.18	-0.86	-88.03
Naive Interpretation	Member

06 - Financial Health · Weak

Rating